In this process, glutamine is first converted to glutamate by glutaminases (GLSs), followed by conversion to α-ketoglutarate (α-KG); a TCA cycle intermediate therapeutically targeting glutaminolysis was proven to be an effective strategy to combat cancer [263]. This evidence concerns the gene SATB2 and cancer.